Page last updated: 2024-09-03

n,n-dimethylarginine and atenolol

n,n-dimethylarginine has been researched along with atenolol in 3 studies

Compound Research Comparison

Studies (n,n-dimethylarginine)	Trials (n,n-dimethylarginine)	Recent Studies (post-2010) (n,n-dimethylarginine)	Studies (atenolol)	Trials (atenolol)	Recent Studies (post-2010) (atenolol)
2,216	228	1,221	5,473	1,950	852

Protein Interaction Comparison

Protein	Taxonomy	atenolol (IC50)
Beta-1 adrenergic receptor	Homo sapiens (human)	0.7468
Alpha-1D adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1A adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1B adrenergic receptor	Homo sapiens (human)	0.23

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boccioletti, V; Cominacini, L; Garbin, U; Manfro, S; Pasini, AF; Stranieri, C	1
Boccioletti, V; Cominacini, L; Cominacini, M; Garbin, U; Manfro, S; Mozzini, C; Pasini, A; Pasini, AF; Stranieri, C	1
Niu, M; Shi, R; Wang, Y; Yin, S; Zhang, F	1

Trials

1 trial(s) available for n,n-dimethylarginine and atenolol

Article	Year
Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. American journal of hypertension, 2008, Volume: 21, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitric Oxide Synthase Type III; Vasodilation	2008

Article

Year

Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.

American journal of hypertension, 2008, Volume: 21, Issue:11

Topics: Adrenergic beta-Antagonists; Aged; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitric Oxide Synthase Type III; Vasodilation

2008

Other Studies

2 other study(ies) available for n,n-dimethylarginine and atenolol

Article	Year
Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity. Pharmacological research, 2007, Volume: 56, Issue:6 Topics: Adrenergic beta-Antagonists; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Cell Line; Endothelial Cells; Ethanolamines; Female; Humans; Male; Nebivolol; Nitric Oxide Synthase Type III; RNA, Messenger	2007
Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway. Pharmacological reports : PR, 2018, Volume: 70, Issue:5 Topics: Amidohydrolases; Angiotensin II; Animals; Arginine; Atenolol; Blood Pressure; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Protective Agents; Protein-Arginine N-Methyltransferases; Rats; Reactive Oxygen Species; Signal Transduction	2018

Article

Year

Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

Pharmacological research, 2007, Volume: 56, Issue:6

Topics: Adrenergic beta-Antagonists; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Cell Line; Endothelial Cells; Ethanolamines; Female; Humans; Male; Nebivolol; Nitric Oxide Synthase Type III; RNA, Messenger

2007

Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.

Pharmacological reports : PR, 2018, Volume: 70, Issue:5

Topics: Amidohydrolases; Angiotensin II; Animals; Arginine; Atenolol; Blood Pressure; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Protective Agents; Protein-Arginine N-Methyltransferases; Rats; Reactive Oxygen Species; Signal Transduction

2018